Scott McTominay’s Heart Treatment: The June Episode and Unanswered Questions Behind His Return

The most useful news from Scott McTominay’s Hampden press conference ahead of Scotland’s November Nations League matches was that he had returned to the squad. He had missed Scotland’s previous four matches under the new coaching setup. But the disclosure he made alongside that return redirected the headlines: during the World Cup in June, his heart rhythm became irregular, he received hospital treatment, and the problem recurred in August. This was not a new medical event that week. It was his public account of an episode from several months earlier. Keeping the timeline clear is the difference here between sensation and information.

McTominay said the irregularity was first detected after Scotland arrived in the United States. About 48 hours before the opening World Cup match against Haiti, he underwent cardioversion in hospital. In his words, his heart was “shocked” and he was put to sleep for the procedure. Those are his words, not a clinical diagnosis. The available description calls the condition a mild, benign heart arrhythmia, but does not specify its type. It would therefore be unjustified to infer a particular illness or future risk from this account alone.

The Scotland camp described his issue at the time as a “stomach complaint.” McTominay later spoke openly about the cardioversion. The difference between those accounts raises the story’s most important institutional question: what was disclosed to the public, who decided what to disclose, and on what basis was he medically cleared to play at the World Cup? The available report does not answer these questions. It records the camp’s earlier explanation and the player’s later disclosure, but does not investigate the process between them.

McTominay played all three group matches after the June episode. Scotland did not progress, and his performances were described as below his usual level. The player himself refused to use the health problem as an excuse for his football. He called it part of the process, not a complete explanation for his performances. That restraint matters: it is easy to assume a connection between a player’s medical history and what happens on the pitch, but the available information does not establish causation. There is not enough evidence to treat the dip in performance and the medical episode as one story.

The events continued away from the pitch. The heart-rhythm problem returned in August while McTominay was in Italy with Napoli. At the start of the season, he played Napoli’s first two Serie A matches. In September he decided to undergo a procedure, and cardiac ablation was performed in Manchester. He missed the rest of September. According to the available account, he had made nine Napoli appearances before the Nations League window. This sequence shows that his return to Scotland was not a decision made in a single day; club-level football and several weeks of recovery preceded it.

Cardioversion and ablation are different procedures. Cardioversion uses a controlled electrical shock in an attempt to restore a normal heart rhythm; ablation targets tissue responsible for abnormal electrical signals. Words such as “shock” and “put to sleep” in McTominay’s account may sound alarming, but those words alone cannot establish how serious his condition was. The public account does not provide the arrhythmia’s name, detailed findings from the procedures, or his doctors’ advice. It would be a mistake to treat the dramatic language in a headline as a diagnosis.

The emotional centre of the press conference was the psychological impact more than the technical details of treatment. McTominay described the period as one of the most disappointing of his career and mentioned his family’s concern. That reaction is understandable for an athlete: control over the body and availability are central to the job, and uncertainty about the heart touches both directly. Still, the report repeated this emotional theme several times while offering limited medical detail. Readers can understand his distress, but learn less about treatment and the conditions of his return.

The report rests mainly on McTominay’s account. He is the primary source for his experience, fear and disappointment. But a player’s own statement is not enough to assess an arrhythmia’s type, risk or the decision to clear him for a match. The available material includes no comment from the Scottish Football Association’s medical staff, Napoli, the treating specialist or an independent sports physician. New Scotland manager Sebastien Pocognoli also does not explain how McTominay’s minutes or workload will be managed after his return. The story presents the player’s experience credibly, but does not verify the medical decisions.

That is why the old “stomach complaint” explanation becomes the report’s most important and least examined detail. A team may need to protect a player’s privacy; it is not necessary to make every medical detail public. But privacy and giving the public a misleading account are different things. When a player receives cardioversion around 48 hours before a World Cup match and then plays, it is reasonable to ask what medical process informed the decision, what risks were explained to the player, and why the public statement was so limited. The facts available do not show that the clearance was wrong. They also do not make the accountability question irrelevant.

Putting “shocked” prominently in a headline can give readers the impression that a new event has occurred or that emergency defibrillation was used. The body of the report provides a clearer context: the disclosure concerned an event in June, while the ablation took place in September. That difference between the headline’s sense of immediacy and the article’s actual timeline is its largest editorial weakness. A stronger opening would emphasise that McTominay had “revealed” the episode and link it to June in the first sentence. The story would retain its significance while reducing the risk that readers misunderstand when it happened.

The return is still concrete news for supporters. Scotland have an option in their matches against North Macedonia and Switzerland who had resumed playing for Napoli after treatment. But the available information does not say whether he will start, whether his minutes will be restricted, or whether he will receive additional monitoring. Being in the squad and being fully match-fit are not the same thing. Only the coach and medical staff can confirm that distinction.

This press conference should therefore be understood neither as a frightening medical headline alone nor as an uncomplicated comeback story. McTominay spoke about his experience and did not use it as an excuse for his form; that is the report’s strongest element. But the specific arrhythmia diagnosis, the clearance before the match, and the decision behind the public explanation remain unresolved. The most useful signal in these November fixtures will be not only whether McTominay returns to the pitch, but how clearly his role and workload are managed. When Scotland’s medical staff and coach explain the limits of his return, supporters will be better placed to understand whether this is a routine selection or a carefully managed comeback.